Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bis(4-fluorophenyl)phenylacetamide
2. Ica 17043
3. Ica-17043
4. Ica17043
1. 289656-45-7
2. 2,2-bis(4-fluorophenyl)-2-phenylacetamide
3. Ica-17043
4. Senicapoc (usan)
5. Senicapoc [usan]
6. Ts6g201a6q
7. Pf-05416266
8. Benzeneacetamide, 4-fluoro-alpha-(4-fluorophenyl)-alpha-phenyl-
9. Bis(4-fluorophenyl)phenylacetamide
10. Senicapoc [usan:inn]
11. Ica 17043
12. Unii-ts6g201a6q
13. 2,2-bis(4-fluorophenyl)-2-phenyl-acetamide
14. 4-fluoro-alpha-(4-fluorophenyl)-alpha-phenylbenzeneacetamide
15. Senicapoc [inn]
16. Senicapoc [mart.]
17. Senicapoc [who-dd]
18. Chembl405821
19. Gtpl2331
20. Schembl1443805
21. Amy2744
22. Dtxsid60276906
23. Hms3741e13
24. Act06676
25. Bcp14507
26. Zinc3816408
27. Bbl102413
28. Bdbm50371391
29. Mfcd09027349
30. Stl556215
31. Akos007930800
32. Cs-0294
33. Db06280
34. 4-methyl-1h-pyrrole-2-carboxylic?acid
35. Hy-50694
36. Ms-20434
37. Db-003217
38. Ft-0660387
39. 2,2-bis(4-fluorophenyl)-2-phenyl-ethanamide
40. C74487
41. D06640
42. 656f457
43. A822267
44. A904983
45. Au-004/43508060
46. Q7450628
47. 4-fluoro-a-(4-fluorophenyl)-a-phenyl-benzeneacetamide
| Molecular Weight | 323.3 g/mol |
|---|---|
| Molecular Formula | C20H15F2NO |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 323.11217043 g/mol |
| Monoisotopic Mass | 323.11217043 g/mol |
| Topological Polar Surface Area | 43.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 397 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in anemia (sickle cell) and asthma.
ABOUT THIS PAGE
A Senicapoc manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Senicapoc, including repackagers and relabelers. The FDA regulates Senicapoc manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Senicapoc API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Senicapoc supplier is an individual or a company that provides Senicapoc active pharmaceutical ingredient (API) or Senicapoc finished formulations upon request. The Senicapoc suppliers may include Senicapoc API manufacturers, exporters, distributors and traders.
Senicapoc Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Senicapoc GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Senicapoc GMP manufacturer or Senicapoc GMP API supplier for your needs.
A Senicapoc CoA (Certificate of Analysis) is a formal document that attests to Senicapoc's compliance with Senicapoc specifications and serves as a tool for batch-level quality control.
Senicapoc CoA mostly includes findings from lab analyses of a specific batch. For each Senicapoc CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Senicapoc may be tested according to a variety of international standards, such as European Pharmacopoeia (Senicapoc EP), Senicapoc JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Senicapoc USP).
LOOKING FOR A SUPPLIER?
